Data catalog

ClinicalTrials.gov studies

About 571K records

More records

Continuing the ClinicalTrials.gov studies list, 1000 records per page, after NCT00003473.

  1. NCT00003474Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma…
  2. NCT00003475Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
  3. NCT00003476Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
  4. NCT00003477Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
  5. NCT00003478Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
  6. NCT00003479Antineoplaston Therapy in Treating Patients With Ependymoma
  7. NCT00003483Antineoplaston Therapy in Treating Patients With Meningioma
  8. NCT00003484Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With…
  9. NCT00003485Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
  10. NCT00003486Antineoplaston Therapy in Treating Patients With Colon Cancer
  11. NCT00003487Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
  12. NCT00003489Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
  13. NCT00003490Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
  14. NCT00003491Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
  15. NCT00003492Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
  16. NCT00003493Combination Chemotherapy in Treating Patients With Multiple Myeloma
  17. NCT00003494Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
  18. NCT00003495Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
  19. NCT00003496Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell…
  20. NCT00003497Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
  21. NCT00003498Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  22. NCT00003499Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
  23. NCT00003500Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV…
  24. NCT00003501Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV…
  25. NCT00003502Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
  26. NCT00003505Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma
  27. NCT00003508Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
  28. NCT00003509Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
  29. NCT00003511Antineoplaston Therapy in Treating Patients With Multiple Myeloma
  30. NCT00003512Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's…
  31. NCT00003513Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory…
  32. NCT00003514Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic…
  33. NCT00003515Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory…
  34. NCT00003516Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
  35. NCT00003517Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
  36. NCT00003518Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell…
  37. NCT00003519Combination Chemotherapy in Treating Women With Breast Cancer
  38. NCT00003520Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
  39. NCT00003521Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
  40. NCT00003522Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
  41. NCT00003523Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial…
  42. NCT00003524Antineoplaston Therapy in Treating Patients With Stomach Cancer
  43. NCT00003525Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or…
  44. NCT00003526Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
  45. NCT00003528Raltitrexed in Treating Children With Refractory Acute Leukemia
  46. NCT00003530Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
  47. NCT00003531Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
  48. NCT00003532Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
  49. NCT00003533Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
  50. NCT00003534Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
  51. NCT00003535Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
  52. NCT00003536Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With…
  53. NCT00003537Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma
  54. NCT00003538Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
  55. NCT00003539Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic…
  56. NCT00003540Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With…
  57. NCT00003541Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in…
  58. NCT00003542Interferon Alfa in Treating Patients With Advanced Kidney Cancer
  59. NCT00003543Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With…
  60. NCT00003544Irinotecan in Treating Patients With Metastatic Colorectal Cancer
  61. NCT00003545506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or…
  62. NCT00003546Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
  63. NCT00003548Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
  64. NCT00003549S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
  65. NCT00003551Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer
  66. NCT00003552Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic…
  67. NCT00003553Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
  68. NCT00003554Rituximab in Treating Patients With Multiple Myeloma
  69. NCT00003555Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or…
  70. NCT00003556Vaccine Therapy in Treating Patients With Melanoma
  71. NCT00003557Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or…
  72. NCT00003558Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
  73. NCT00003560Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian…
  74. NCT00003561Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase…
  75. NCT00003562Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell…
  76. NCT00003563Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
  77. NCT00003564Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant…
  78. NCT00003565Docetaxel in Treating Patients With Solid Tumors
  79. NCT00003566Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
  80. NCT00003567Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or…
  81. NCT00003568Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
  82. NCT00003569Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin…
  83. NCT00003571Gene Testing in Patients With Colon Cancer
  84. NCT00003572Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow…
  85. NCT00003573Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children…
  86. NCT00003574Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain…
  87. NCT00003575Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated…
  88. NCT00003576Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating…
  89. NCT00003577Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or…
  90. NCT00003578High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients…
  91. NCT00003580Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and…
  92. NCT00003582Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head…
  93. NCT00003583Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and…
  94. NCT00003584Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent…
  95. NCT00003585Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent…
  96. NCT00003587S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small…
  97. NCT00003588Gene Therapy in Treating Patients With Ovarian Cancer
  98. NCT00003589Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
  99. NCT00003590S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
  100. NCT00003591Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable…
  101. NCT00003592Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck…
  102. NCT00003593Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder…
  103. NCT00003594Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  104. NCT00003595Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients…
  105. NCT00003596Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal…
  106. NCT00003597Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
  107. NCT00003598UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia
  108. NCT00003599Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who…
  109. NCT00003600Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
  110. NCT00003601Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome
  111. NCT00003602Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
  112. NCT00003603Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
  113. NCT00003604Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been…
  114. NCT00003605Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV…
  115. NCT00003606Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
  116. NCT00003607Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate…
  117. NCT00003610Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
  118. NCT00003611Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who…
  119. NCT00003612Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer
  120. NCT00003613O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell…
  121. NCT00003614Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
  122. NCT00003615Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
  123. NCT00003616Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
  124. NCT00003617Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in…
  125. NCT00003619Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin…
  126. NCT00003620Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia
  127. NCT00003621Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic…
  128. NCT00003622Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is…
  129. NCT00003623High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in…
  130. NCT00003624Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine…
  131. NCT00003625Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed…
  132. NCT00003626Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded…
  133. NCT00003627Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With…
  134. NCT00003630Arsenic Trioxide in Treating Patients With Advanced Solid Tumors
  135. NCT00003631Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed…
  136. NCT00003632Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients…
  137. NCT00003633Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
  138. NCT00003634Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or…
  139. NCT00003635506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to…
  140. NCT00003636Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian…
  141. NCT00003637Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating…
  142. NCT00003638Vaccine Therapy in Treating Women With Metastatic Breast Cancer
  143. NCT00003639Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With…
  144. NCT00003640Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or…
  145. NCT00003641High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
  146. NCT00003642Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or…
  147. NCT00003643Combination Chemotherapy in Treating Men With Germ Cell Cancer
  148. NCT00003644Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating…
  149. NCT00003645Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer…
  150. NCT00003646Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
  151. NCT00003647Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV…
  152. NCT00003648Genetic Study of Patients and Families With a History of Colorectal Cancer
  153. NCT00003649Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be…
  154. NCT00003650Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
  155. NCT00003652Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or…
  156. NCT00003653Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy…
  157. NCT00003654Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast…
  158. NCT00003656Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
  159. NCT00003657High-dose ICE With Amifostine
  160. NCT00003658Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic…
  161. NCT00003659Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic…
  162. NCT00003661Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating…
  163. NCT00003662Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other…
  164. NCT00003663Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent…
  165. NCT00003664Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer…
  166. NCT00003665Vaccine Therapy in Treating Patients With Stage IV Melanoma
  167. NCT00003666Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer
  168. NCT00003667Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk…
  169. NCT00003669Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced…
  170. NCT00003670Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory…
  171. NCT00003671Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic…
  172. NCT00003673CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse
  173. NCT00003674Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast…
  174. NCT00003675Topotecan in Treating Patients With Myelodysplastic Syndrome
  175. NCT00003677Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
  176. NCT00003678Tamoxifen in Treating Women With Breast Cancer
  177. NCT00003679Combination Chemotherapy in Treating Women With Breast Cancer
  178. NCT00003680Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell…
  179. NCT00003681Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome
  180. NCT00003682Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic…
  181. NCT00003683Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
  182. NCT00003684Theophylline in Treating Cancer Patients With Shortness of Breath
  183. NCT00003685Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer
  184. NCT00003686Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
  185. NCT00003687Treatment for Chronic Pain in Patients With Advanced Cancer
  186. NCT00003688Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic…
  187. NCT00003690Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors
  188. NCT00003691Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage…
  189. NCT00003692Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer
  190. NCT00003693Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia…
  191. NCT00003694Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed…
  192. NCT00003695Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III…
  193. NCT00003696Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung…
  194. NCT00003697Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
  195. NCT00003698Chemotherapy in Treating Patients With Solid Tumors
  196. NCT00003700Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
  197. NCT00003701Combination Chemotherapy in Treating Patients With Bladder Cancer
  198. NCT00003702Methotrexate Compared With Dactinomycin in Treating Patients With Gestational…
  199. NCT00003703Chemotherapy in Treating Patients With Advanced Solid Tumors
  200. NCT00003704Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or…
  201. NCT00003705BMS-184476 in Treating Patients With Advanced Solid Tumors
  202. NCT00003706LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying…
  203. NCT00003707Combination Chemotherapy in Treating Patients With Advanced Cancer
  204. NCT00003708Chemotherapy in Treating Patients With Advanced Solid Tumors
  205. NCT00003709Chemotherapy in Treating Patients With Advanced Solid Tumors
  206. NCT00003710Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors
  207. NCT00003711Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors
  208. NCT00003712CCI-779 in Treating Patients With Advanced Solid Tumors
  209. NCT00003713Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors
  210. NCT00003714Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
  211. NCT00003715Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
  212. NCT00003716Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder…
  213. NCT00003717Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
  214. NCT00003718Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
  215. NCT00003719Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma
  216. NCT00003720SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
  217. NCT00003721Chemotherapy in Treating Patients With Advanced Solid Tumors
  218. NCT00003723S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the…
  219. NCT00003724Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
  220. NCT00003725Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or…
  221. NCT00003726Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer
  222. NCT00003727Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in…
  223. NCT00003728Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute…
  224. NCT00003729Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute…
  225. NCT00003730Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer
  226. NCT00003731Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
  227. NCT00003732Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV…
  228. NCT00003733Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for…
  229. NCT00003734Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With…
  230. NCT00003735Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or…
  231. NCT00003736MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
  232. NCT00003737Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
  233. NCT00003739Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever…
  234. NCT00003740Trastuzumab in Treating Patients With Prostate Cancer
  235. NCT00003741Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell…
  236. NCT00003742Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid…
  237. NCT00003743Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction…
  238. NCT00003744Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be…
  239. NCT00003745Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
  240. NCT00003746Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
  241. NCT00003747Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
  242. NCT00003748Irinotecan in Treating Patients With Esophageal or Stomach Cancer
  243. NCT00003749Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With…
  244. NCT00003750Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or…
  245. NCT00003751Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With…
  246. NCT00003752Bexarotene in Treating Patients With Metastatic Breast Cancer
  247. NCT00003753Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver…
  248. NCT00003754Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory…
  249. NCT00003755Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor
  250. NCT00003757Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following…
  251. NCT00003758Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
  252. NCT00003759AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or…
  253. NCT00003760Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
  254. NCT00003761Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
  255. NCT00003762Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell…
  256. NCT00003763Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer
  257. NCT00003764Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic…
  258. NCT00003765O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
  259. NCT00003766O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be…
  260. NCT00003768Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors
  261. NCT00003769Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III…
  262. NCT00003771Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With…
  263. NCT00003772Quality-of-Life Assessment in Patients With Ovarian Cancer
  264. NCT00003773IM-862 in Treating Patients With Recurrent Ovarian Cancer
  265. NCT00003775Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse
  266. NCT00003776Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic…
  267. NCT00003777Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With…
  268. NCT00003778Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma
  269. NCT00003779Biological Therapy in Treating Patients With Bladder Cancer
  270. NCT00003780Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the…
  271. NCT00003781Docetaxel in Treating Patients With Stage IV Prostate Cancer
  272. NCT00003782Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3…
  273. NCT00003783Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic…
  274. NCT00003784S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With…
  275. NCT00003786Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  276. NCT00003787Women's Healthy Eating and Living Study
  277. NCT00003788Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in…
  278. NCT00003789Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced…
  279. NCT00003790Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or…
  280. NCT00003792Vaccine Therapy in Treating Patients With Metastatic Melanoma
  281. NCT00003793Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
  282. NCT00003794Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
  283. NCT00003795Quality of Life in Survivors of Gynecologic Cancer
  284. NCT00003796Irofulven in Treating Patients With Metastatic Breast Cancer
  285. NCT00003797Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of…
  286. NCT00003798Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the…
  287. NCT00003799Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced…
  288. NCT00003800Diagnostic Study of Patients With Stage I Testicular Cancer
  289. NCT00003801Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma
  290. NCT00003802Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
  291. NCT00003803Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage…
  292. NCT00003804Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
  293. NCT00003805Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by…
  294. NCT00003808Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic…
  295. NCT00003809Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic…
  296. NCT00003810Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer…
  297. NCT00003811Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell…
  298. NCT00003812Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell…
  299. NCT00003814Eflornithine in Treating Patients With Bladder Cancer
  300. NCT00003815Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients…
  301. NCT00003816Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic…
  302. NCT00003817Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting…
  303. NCT00003819Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
  304. NCT00003820Rituximab in Treating Patients With Hodgkin's Lymphoma
  305. NCT00003821Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
  306. NCT00003822SR-45023A in Treating Patients With Advanced Solid Tumors
  307. NCT00003824S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
  308. NCT00003825Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by…
  309. NCT00003827Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
  310. NCT00003828S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
  311. NCT00003829Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
  312. NCT00003830Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit…
  313. NCT00003831Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung…
  314. NCT00003832Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
  315. NCT00003833Genetic Study in Patients With Stage II or Stage III Colon Cancer
  316. NCT00003834Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
  317. NCT00003835Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
  318. NCT00003837506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic…
  319. NCT00003838Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
  320. NCT00003840DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid…
  321. NCT00003842IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
  322. NCT00003843Irinotecan in Treating Patients With Colorectal Cancer
  323. NCT00003846Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating…
  324. NCT00003847VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small…
  325. NCT00003849Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
  326. NCT00003850Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  327. NCT00003851Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez…
  328. NCT00003852Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients…
  329. NCT000038534'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
  330. NCT00003854Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I…
  331. NCT00003855Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
  332. NCT00003856Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary…
  333. NCT00003857Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal…
  334. NCT00003858Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for…
  335. NCT00003859Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With…
  336. NCT00003860Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients…
  337. NCT00003861Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic…
  338. NCT00003862Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
  339. NCT00003863Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
  340. NCT00003864Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus
  341. NCT00003865Toremifene in Treating Patients With Ovarian Cancer
  342. NCT00003867Irinotecan and Capecitabine in Treating Patients With Solid Tumors
  343. NCT00003868Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By…
  344. NCT00003869Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung…
  345. NCT00003870Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by…
  346. NCT00003871PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
  347. NCT00003873Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal…
  348. NCT00003874Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
  349. NCT00003875Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose…
  350. NCT00003876Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or…
  351. NCT00003877Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in…
  352. NCT00003878Carmustine Implants in Treating Patients With Brain Metastases
  353. NCT00003880Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly…
  354. NCT00003881Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung…
  355. NCT00003882Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors
  356. NCT00003883Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing…
  357. NCT00003884Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
  358. NCT00003885Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic…
  359. NCT00003887Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or…
  360. NCT00003888Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head…
  361. NCT00003890MG98 in Treating Patients With Advanced Solid Tumors
  362. NCT00003891Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors
  363. NCT00003892ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
  364. NCT00003893Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast…
  365. NCT00003894Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone…
  366. NCT00003895Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma
  367. NCT00003896S9912 Combination Chemo in Stage III Ovarian Cancer,
  368. NCT00003897Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant…
  369. NCT00003898Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell…
  370. NCT00003899Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients…
  371. NCT00003900Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell…
  372. NCT00003901Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small…
  373. NCT00003902Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer…
  374. NCT00003903Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases…
  375. NCT00003906Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in…
  376. NCT00003907Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the…
  377. NCT00003908S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head…
  378. NCT00003909Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed…
  379. NCT00003910Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic…
  380. NCT00003911S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited…
  381. NCT00003912Chemotherapy in Treating Children With Liver Cancer
  382. NCT00003913Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or…
  383. NCT00003914Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
  384. NCT00003916Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating…
  385. NCT00003917Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
  386. NCT00003920Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in…
  387. NCT00003923Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or…
  388. NCT00003924Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in…
  389. NCT00003925Combination Chemotherapy In Treating Patients With Advanced Cancer
  390. NCT00003926Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
  391. NCT00003927Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating…
  392. NCT00003928Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
  393. NCT00003929Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central…
  394. NCT00003930Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage…
  395. NCT00003931Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
  396. NCT00003933Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute…
  397. NCT00003934Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide…
  398. NCT00003935Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed…
  399. NCT00003936Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
  400. NCT00003937Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed…
  401. NCT00003938Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in…
  402. NCT00003939Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
  403. NCT00003941Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men…
  404. NCT00003942Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients…
  405. NCT00003943Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients…
  406. NCT00003944Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients…
  407. NCT00003945Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent…
  408. NCT00003946Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
  409. NCT00003950Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally…
  410. NCT00003951DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
  411. NCT00003953Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast…
  412. NCT00003954Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell…
  413. NCT00003955Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic…
  414. NCT00003956Combination Chemotherapy in Treating Patients With Advanced Cancer
  415. NCT00003957Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients…
  416. NCT00003958Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
  417. NCT00003959Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
  418. NCT00003960Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  419. NCT00003961Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic…
  420. NCT00003962Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic…
  421. NCT00003963Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell…
  422. NCT00003966Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell…
  423. NCT00003967Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or…
  424. NCT00003968Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
  425. NCT00003969Geldanamycin Analogue in Treating Patients With Advanced Cancer
  426. NCT00003970Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
  427. NCT00003972Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients…
  428. NCT00003974Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell…
  429. NCT00003976E7070 in Treating Patients With Solid Tumors
  430. NCT00003977Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer
  431. NCT00003979CHS 828 in Treating Patients With Solid Tumors
  432. NCT00003980BIBX 1382 in Treating Patients With Solid Tumors
  433. NCT00003981E7070 in Treating Patients With Solid Tumors
  434. NCT00003982MEN-10755 in Treating Patients With Solid Tumors
  435. NCT00003984Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
  436. NCT00003985KRN7000 in Treating Patients With Solid Tumors
  437. NCT00003989ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell…
  438. NCT00003991Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid…
  439. NCT00003992Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage…
  440. NCT00003993Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or…
  441. NCT00003994Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver…
  442. NCT00003995Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer…
  443. NCT00003996Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed…
  444. NCT000039976-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome…
  445. NCT00003998Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial…
  446. NCT00004001S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not…
  447. NCT00004002PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
  448. NCT00004003Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer…
  449. NCT00004004Procarbazine in Treating Patients With Recurrent Brain Tumor
  450. NCT00004005Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or…
  451. NCT00004006Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating…
  452. NCT00004008Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
  453. NCT00004009R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic…
  454. NCT00004010Combination Chemotherapy and Radiation Therapy in Treating Children With Previously…
  455. NCT00004011S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With…
  456. NCT00004012Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary…
  457. NCT00004013Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in…
  458. NCT00004014Liposomal Doxorubicin in Treating Patients With Prostate Cancer
  459. NCT00004015Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma…
  460. NCT00004016Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid…
  461. NCT00004017Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or…
  462. NCT00004022Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV…
  463. NCT00004024Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With…
  464. NCT00004025Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage…
  465. NCT00004026CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to…
  466. NCT00004028Carmustine in Treating Patients With Recurrent Malignant Glioma
  467. NCT00004029Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
  468. NCT00004030VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
  469. NCT00004031SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With…
  470. NCT00004032Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian…
  471. NCT00004033Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural…
  472. NCT00004036Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
  473. NCT00004037Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal…
  474. NCT00004038Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
  475. NCT00004039Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage…
  476. NCT00004040Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic…
  477. NCT00004041Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
  478. NCT00004042Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer
  479. NCT00004043Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate…
  480. NCT00004045Chemotherapy in Treating Patients With Prostate Cancer
  481. NCT00004046Chemotherapy in Treating Women With Metastatic Breast Cancer
  482. NCT00004047Chemotherapy in Treating Patients Who Have Hematologic Cancer
  483. NCT00004048Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation…
  484. NCT00004049SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  485. NCT00004050Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate…
  486. NCT00004051Irinotecan in Treating Patients With Advanced Solid Tumors
  487. NCT00004052Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
  488. NCT00004054Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in…
  489. NCT00004055Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated…
  490. NCT00004056Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in…
  491. NCT00004057Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors…
  492. NCT0000405812-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone…
  493. NCT00004059Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors
  494. NCT00004060Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian…
  495. NCT00004061Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and…
  496. NCT00004062Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid…
  497. NCT00004063Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With…
  498. NCT00004064Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or…
  499. NCT00004065Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic…
  500. NCT00004066Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent…
  501. NCT00004067Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating…
  502. NCT00004068Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly…
  503. NCT00004070Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and…
  504. NCT00004071Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV…
  505. NCT00004072O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
  506. NCT00004073Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma…
  507. NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of…
  508. NCT0000407517-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That…
  509. NCT00004076PNU 166148 in Treating Patients With Metastatic Solid Tumors
  510. NCT00004077Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular…
  511. NCT00004078Irinotecan in Treating Children With Refractory Solid Tumors
  512. NCT00004079Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid…
  513. NCT00004080Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors
  514. NCT00004081Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
  515. NCT00004082Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed…
  516. NCT00004083Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
  517. NCT00004084Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
  518. NCT00004085Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With…
  519. NCT00004086Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell…
  520. NCT00004087Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in…
  521. NCT00004088Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and…
  522. NCT00004089Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid…
  523. NCT00004090Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors
  524. NCT00004091Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
  525. NCT00004092Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
  526. NCT00004093Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III…
  527. NCT00004094Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously…
  528. NCT00004095Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid…
  529. NCT00004096Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small…
  530. NCT00004097Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or…
  531. NCT00004099Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
  532. NCT00004100Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  533. NCT00004101Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  534. NCT00004102Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  535. NCT00004103Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
  536. NCT00004104Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients…
  537. NCT00004105Combination Chemotherapy in Treating Patients With Advanced Cancer
  538. NCT00004106Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
  539. NCT00004107Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in…
  540. NCT00004108DX-8951f in Treating Patients With Liver Cancer
  541. NCT00004109Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue…
  542. NCT00004110Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
  543. NCT00004112Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly…
  544. NCT00004113Temozolomide in Treating Patients With Recurrent Malignant Glioma
  545. NCT00004114Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced…
  546. NCT00004115Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal…
  547. NCT00004122BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
  548. NCT00004123Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or…
  549. NCT00004124S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have…
  550. NCT00004125Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That…
  551. NCT00004126Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell…
  552. NCT00004127Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent…
  553. NCT00004128Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating…
  554. NCT00004129Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
  555. NCT00004132Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
  556. NCT00004135Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma…
  557. NCT00004136Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
  558. NCT00004137S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell…
  559. NCT00004138Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
  560. NCT00004139Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV…
  561. NCT00004141Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic…
  562. NCT00004142Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With…
  563. NCT00004143Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies &…
  564. NCT00004144Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
  565. NCT00004145Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in…
  566. NCT00004146Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
  567. NCT00004147COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors
  568. NCT00004148Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma
  569. NCT00004149Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded…
  570. NCT00004150High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus…
  571. NCT00004151Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer
  572. NCT00004152PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
  573. NCT00004153Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
  574. NCT00004154Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer
  575. NCT00004156Vaccine Therapy in Treating Patients With Breast Cancer
  576. NCT00004157Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients…
  577. NCT00004158Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell…
  578. NCT00004159Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer…
  579. NCT00004160Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell…
  580. NCT00004161Fenretinide in Treating Patients With Leukoplakia of the Mouth
  581. NCT00004162Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With…
  582. NCT00004163Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
  583. NCT00004164Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV…
  584. NCT00004165Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With…
  585. NCT00004166Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving…
  586. NCT00004169Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating…
  587. NCT00004171Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With…
  588. NCT00004172Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating…
  589. NCT00004173Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
  590. NCT00004174Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating…
  591. NCT00004175Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast…
  592. NCT00004176Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage…
  593. NCT00004177Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating…
  594. NCT00004178Gene Therapy in Treating Patients With Cancer
  595. NCT00004179Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed…
  596. NCT00004180Rosiglitazone in Treating Patients With Liposarcoma
  597. NCT00004181Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase…
  598. NCT00004182Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer
  599. NCT00004183Capecitabine in Treating Patients With Malignant Mesothelioma
  600. NCT00004184Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
  601. NCT00004186Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
  602. NCT00004187Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal…
  603. NCT00004188Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients…
  604. NCT00004189Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With…
  605. NCT00004190Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or…
  606. NCT00004192Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's…
  607. NCT00004193ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer
  608. NCT00004194Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease
  609. NCT00004195Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
  610. NCT00004196Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
  611. NCT00004197Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated…
  612. NCT00004198Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV…
  613. NCT00004199Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent…
  614. NCT00004200Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly…
  615. NCT00004201Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV…
  616. NCT00004202Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III…
  617. NCT00004203Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
  618. NCT00004204Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
  619. NCT00004205Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
  620. NCT00004206Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer
  621. NCT00004207Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
  622. NCT00004208Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
  623. NCT00004209Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell…
  624. NCT00004210Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing…
  625. NCT00004211Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
  626. NCT00004212DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
  627. NCT000042133-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
  628. NCT00004215Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
  629. NCT00004216VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not…
  630. NCT00004217S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly…
  631. NCT00004218Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
  632. NCT00004219Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being…
  633. NCT00004220Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
  634. NCT00004221Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients…
  635. NCT00004223Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic…
  636. NCT00004224Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized…
  637. NCT00004225Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
  638. NCT00004226Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary…
  639. NCT00004227Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage…
  640. NCT00004228Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or…
  641. NCT00004229Endostatin in Treating Patients With Advanced Solid Tumors
  642. NCT00004230Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
  643. NCT00004231Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or…
  644. NCT00004232Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic…
  645. NCT00004233S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With…
  646. NCT00004234Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx…
  647. NCT00004235Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or…
  648. NCT00004236Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
  649. NCT00004237Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or…
  650. NCT0000423810-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV…
  651. NCT00004239506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
  652. NCT0000424117-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial…
  653. NCT00004242Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
  654. NCT00004243Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
  655. NCT00004244Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or…
  656. NCT00004245Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute…
  657. NCT00004246Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of…
  658. NCT00004248Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be…
  659. NCT00004249Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has…
  660. NCT00004250Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue…
  661. NCT00004251Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
  662. NCT00004252Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic…
  663. NCT00004253Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage…
  664. NCT00004254Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically…
  665. NCT00004255Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or…
  666. NCT00004256Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal…
  667. NCT00004257Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary…
  668. NCT00004258EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer
  669. NCT00004259Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic…
  670. NCT00004260Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  671. NCT00004261EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or…
  672. NCT00004262Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial…
  673. NCT00004263Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous…
  674. NCT00004264Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell…
  675. NCT00004265Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer
  676. NCT00004266Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2…
  677. NCT00004268Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
  678. NCT00004274Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome
  679. NCT00004275Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated…
  680. NCT00004276Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV…
  681. NCT00004278Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital…
  682. NCT00004284Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for…
  683. NCT00004285Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
  684. NCT00004286Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in…
  685. NCT00004287Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic…
  686. NCT00004288Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
  687. NCT00004293Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease
  688. NCT00004294Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into…
  689. NCT00004296Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
  690. NCT00004297Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment…
  691. NCT00004300Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis
  692. NCT00004305Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA…
  693. NCT00004306Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
  694. NCT00004307Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
  695. NCT00004310Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With…
  696. NCT00004311Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin…
  697. NCT00004312Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic…
  698. NCT00004313Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone…
  699. NCT00004314Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine…
  700. NCT00004315Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol…
  701. NCT00004316Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and…
  702. NCT00004317Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital…
  703. NCT00004323Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With…
  704. NCT00004324Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in…
  705. NCT00004325Study of the Neurobiology of Tourette Syndrome and Related Disorders
  706. NCT00004326Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome
  707. NCT00004327Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for…
  708. NCT00004328Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene…
  709. NCT00004329Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy
  710. NCT00004330Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of…
  711. NCT00004331Studies in Porphyria I: Characterization of Enzyme Defects
  712. NCT00004332Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone…
  713. NCT00004333Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I
  714. NCT00004334Study of Depression, Peptides, and Steroids in Cushing's Syndrome
  715. NCT00004335Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the…
  716. NCT00004336Pilot Study of Familial Nonsyndromal Mondini Dysplasia
  717. NCT00004338Study of Zinc for Wilson Disease
  718. NCT00004339Study of Tetrathiomolybdate in Patients With Wilson Disease
  719. NCT00004340Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on…
  720. NCT00004341Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders
  721. NCT00004342International Registry for Severe Chronic Neutropenia
  722. NCT00004343Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's…
  723. NCT00004344Purification of Testis-Stimulating Factor in Precocious Puberty
  724. NCT00004345Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome
  725. NCT00004346Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic…
  726. NCT00004347Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
  727. NCT00004348Study of Protein Translocation in Patients With Beta-Oxidation Disorders
  728. NCT00004350Evaluation of Fanconi Syndrome and Cystinosis
  729. NCT00004351Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion…
  730. NCT00004353Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia
  731. NCT00004354Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable…
  732. NCT00004356Study of Homocysteine Metabolism in Homocystinuria
  733. NCT00004357Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
  734. NCT00004358Phase II Study of Calcitonin for Tumoral Calcinosis
  735. NCT00004359Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
  736. NCT00004360Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
  737. NCT00004361Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in…
  738. NCT00004363Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes…
  739. NCT00004364Study of Novel Types of Familial Diabetes Insipidus
  740. NCT00004365Study of Pituitary Size and Function in Familial Dwarfism of Sindh
  741. NCT00004366Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular…
  742. NCT00004367Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia
  743. NCT00004368Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
  744. NCT00004373Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam…
  745. NCT00004374Study of Systemic Amyloidosis Presentation and Prognosis
  746. NCT00004375Ultraviolet Light Therapy for Systemic Lupus Erythematosus
  747. NCT00004376Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette…
  748. NCT00004378Stem Cell Transplantation (SCT) for Genetic Diseases
  749. NCT00004380Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis
  750. NCT00004381Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
  751. NCT00004382Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature…
  752. NCT00004386Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase…
  753. NCT00004387Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's…
  754. NCT00004390Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of…
  755. NCT00004392Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological…
  756. NCT00004393Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
  757. NCT00004396Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
  758. NCT00004397Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of…
  759. NCT00004398Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute…
  760. NCT00004399Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic…
  761. NCT00004400Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal…
  762. NCT00004401Study of Human Botulism Immunoglobulin in Infants With Botulism
  763. NCT00004402Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital…
  764. NCT00004403Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
  765. NCT00004404Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
  766. NCT00004406Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic…
  767. NCT00004407Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal…
  768. NCT00004408Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell…
  769. NCT00004409Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's…
  770. NCT00004410Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral…
  771. NCT00004412Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With…
  772. NCT00004414Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for…
  773. NCT00004415Study of Combined Intercostal and Diaphragm Pacing for Artificial Respiration in…
  774. NCT00004416Randomized Study of Botulinum Toxin Type A for Achalasia
  775. NCT00004418Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
  776. NCT00004419Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin…
  777. NCT00004420Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
  778. NCT00004421Deep Brain Stimulation in Treating Patients With Dystonia
  779. NCT00004422Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis…
  780. NCT00004423Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease
  781. NCT00004424Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring…
  782. NCT00004426Leuprolide in Determining the Cause of Gonadotropin Deficiency
  783. NCT00004428Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic…
  784. NCT00004429Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis…
  785. NCT00004430Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal…
  786. NCT00004431Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia
  787. NCT00004433Randomized Study of Pergolide in Children With Tourette Syndrome
  788. NCT00004436Randomized Study of Hormonal Regulation of Infantile Hemangioma
  789. NCT00004437Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following…
  790. NCT00004438Leuprolide in Treating Adults With Hypogonadotropism
  791. NCT00004440Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis
  792. NCT00004441Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
  793. NCT00004442Study of Bile Acids in Patients With Peroxisomal Disorders
  794. NCT00004443Study of NTBC for Tyrosinemia I
  795. NCT00004444Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated…
  796. NCT00004445Study of an Implantable Functional Neuromuscular Stimulation System for Patients With…
  797. NCT00004446Study of Fluoxetine in Patients With Depersonalization Disorder
  798. NCT00004448Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A…
  799. NCT00004449Randomized Study of Intensive One-on-one Behavioral Treatment for Preschool Aged Children…
  800. NCT00004450Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy
  801. NCT00004451Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly…
  802. NCT00004454Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into…
  803. NCT00004457Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
  804. NCT00004458Longitudinal and Biological Study of Childhood Disintegrative Disorder
  805. NCT00004464Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal…
  806. NCT00004465Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic…
  807. NCT00004466Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic…
  808. NCT00004467Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by…
  809. NCT00004468Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis
  810. NCT00004471Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated…
  811. NCT00004474Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin…
  812. NCT00004475Genetic Linkage Study for Hereditary Pancreatitis
  813. NCT00004478Droxidopa in Treating Patients With Neurogenic Hypotension
  814. NCT00004479Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally…
  815. NCT00004480Study of Botulinum Toxin in Patients With Primary Hyperhidrosis
  816. NCT00004481Genetic Study of Sitosterolemia
  817. NCT00004482Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and…
  818. NCT00004483NF2 Natural History Consortium
  819. NCT00004485Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
  820. NCT00004486Randomized Study of Fluoxetine in Children and Adolescents With Autism
  821. NCT00004487Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With…
  822. NCT00004488Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's…
  823. NCT00004489Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related…
  824. NCT00004490Phase III Randomized Study of Sodium Dichloroacetate in Children With Congenital Lactic…
  825. NCT00004492Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With…
  826. NCT00004493Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital…
  827. NCT00004494Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress…
  828. NCT00004495Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage…
  829. NCT00004496Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure
  830. NCT00004497Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
  831. NCT00004498Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase…
  832. NCT00004500Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium…
  833. NCT00004533Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic…
  834. NCT00004547Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
  835. NCT00004549Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing…
  836. NCT00004550Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related…
  837. NCT00004551Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch)
  838. NCT00004552Acamprosate Treatment: Mechanisms of Action
  839. NCT00004553Electromyography to Diagnose Neuromuscular Disorders
  840. NCT00004554Sertraline for Alcohol Dependence and Depression
  841. NCT00004556The Effects of Dextroamphetamine on Brain Function
  842. NCT00004557Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders
  843. NCT00004558Antiarrhythmic Effects of N-3 Fatty Acids
  844. NCT00004559Fatty Acid Antiarrhythmia Trial (FAAT)
  845. NCT00004560Public Access Defibrillation (PAD) Community Trial
  846. NCT00004561Treatment of Hypertension With Two Exercise Intensities
  847. NCT00004562Occluded Artery Trial (OAT)
  848. NCT00004563Scleroderma Lung Disease
  849. NCT00004564The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin…
  850. NCT00004565Susceptibility to Breast Cancer
  851. NCT00004566Study of Fetal Swallowing
  852. NCT00004567Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's…
  853. NCT00004568Study of Inherited Neurological Disorders
  854. NCT00004569Incorporating Flow Limitation Into the Diagnosis and Quantification of Sleep Disordered…
  855. NCT00004570Hereditary Deficits in Auditory Processing Leading to Language Impairment
  856. NCT00004571Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
  857. NCT00004572Identification and Therapy Efficacy of Type 2 Diabetes in Hispanic Patients
  858. NCT00004573Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative…
  859. NCT00004574Vitamin Replacement in Abetalipoproteinemia
  860. NCT00004575Effects of Miconazole on Blood Flow
  861. NCT00004576Study of LY300164 for the Treatment of Parkinson's Disease
  862. NCT00004577Study of New Magnetic Resonance Imaging Methods of the Brain
  863. NCT00004578ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral…
  864. NCT00004579A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
  865. NCT00004580A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease…
  866. NCT00004581A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have…
  867. NCT00004582ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One…
  868. NCT00004583A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive…
  869. NCT00004584Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients…
  870. NCT00004585A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected…
  871. NCT00004604Biological Therapy in Treating Patients With Metastatic Cancer
  872. NCT00004635Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
  873. NCT00004637Double-Blind, Placebo-Controlled Trial of Vitamin E as Add-on Therapy for Children With…
  874. NCT00004638Immunologic Aspects of the Pathogenesis of Chronic Sinusitis in Children
  875. NCT00004639Cleft Palate Surgery and Speech Development
  876. NCT00004640"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")
  877. NCT00004642Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in…
  878. NCT00004643Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus
  879. NCT00004644Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated…
  880. NCT00004645Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute…
  881. NCT00004646Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy
  882. NCT00004647Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful…
  883. NCT00004648Studies of Hereditary Hemorrhagic Telangiectasia
  884. NCT00004649Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic…
  885. NCT00004650Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on…
  886. NCT00004652Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in…
  887. NCT00004654Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for…
  888. NCT00004656Nutritional Aspects of Rett Syndrome
  889. NCT00004658Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving…
  890. NCT00004659Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain…
  891. NCT00004660Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
  892. NCT00004661Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism
  893. NCT00004662Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in…
  894. NCT00004663Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus
  895. NCT00004664Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus…
  896. NCT00004665Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
  897. NCT00004667Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease
  898. NCT00004669Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
  899. NCT00004670Phase II Study of Pallidotomy for Parkinson Disease
  900. NCT00004682Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate…
  901. NCT00004685Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy
  902. NCT00004686Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of…
  903. NCT00004688Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent…
  904. NCT00004689Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex…
  905. NCT00004690Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
  906. NCT00004694Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations
  907. NCT00004695Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common…
  908. NCT00004696Study of Morphine in Postoperative Infants to Allow Normal Ventilation
  909. NCT00004697Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total…
  910. NCT00004699Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With…
  911. NCT00004700Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in…
  912. NCT00004705Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis
  913. NCT00004727Antiplatelet Therapy to Prevent Stroke in African Americans
  914. NCT00004728Aspirin Or Warfarin To Prevent Stroke
  915. NCT00004729Ketogenic Diet for Child Epilepsy and Seizure Control
  916. NCT00004730Magnesium Sulfate For Brain Injury
  917. NCT00004731Parkinson's Disease Treatment With Coenzyme Q10
  918. NCT00004732Carotid Revascularization Endarterectomy Versus Stenting Trial
  919. NCT00004733Timing of Levodopa Treatment in Parkinson's Disease
  920. NCT00004734Vitamin Therapy for Prevention of Stroke
  921. NCT00004735The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults…
  922. NCT00004736Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis
  923. NCT00004738Genetic Analysis of the Chiari I Malformation
  924. NCT00004739The Metabolic Effects of Protease Inhibitors in HIV Infected Children
  925. NCT00004740Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for…
  926. NCT00004744Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune…
  927. NCT00004747Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid…
  928. NCT00004748Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
  929. NCT00004751Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy Vs Physiotherapy…
  930. NCT00004753Long-Term Study of Cerebral Glucose Metabolism in Huntington's Disease
  931. NCT00004754Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary…
  932. NCT00004755Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
  933. NCT00004756Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus
  934. NCT00004757Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal…
  935. NCT00004758Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug…
  936. NCT00004759Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal…
  937. NCT00004760Study of Axial Mobility Exercises in Parkinson Disease
  938. NCT00004761Establishment of the National Epidermolysis Bullosa Registry
  939. NCT00004762Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary…
  940. NCT00004763Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and…
  941. NCT00004767Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and…
  942. NCT00004769Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
  943. NCT00004770Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy
  944. NCT00004771Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other…
  945. NCT00004772Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune…
  946. NCT00004773Study of Cardiac and Paroxysmal Abnormalities in Rett Syndrome
  947. NCT00004776Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for…
  948. NCT00004778Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal…
  949. NCT00004779Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis…
  950. NCT00004781Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups
  951. NCT00004784Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary…
  952. NCT00004785Phase III Randomized, Double-Blind Study of Dexamethasone Vs…
  953. NCT00004786Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for…
  954. NCT00004787Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow…
  955. NCT00004788Study of Nutritional Factors in Porphyria
  956. NCT00004789Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria
  957. NCT00004791Study of the Nutritional, Metabolic, and Body Composition Profile in Children and…
  958. NCT00004793Pilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion…
  959. NCT00004794Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis
  960. NCT00004795Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone…
  961. NCT00004796Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
  962. NCT00004797Pilot Study of Fructose for Sickle Cell Crisis
  963. NCT00004799Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell…
  964. NCT00004800Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell…
  965. NCT00004801Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency
  966. NCT00004802Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for…
  967. NCT00004804Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic…
  968. NCT00004805Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on…
  969. NCT00004806Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis
  970. NCT00004807Study of the Pathogenesis of Rett Syndrome
  971. NCT00004808Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
  972. NCT00004809Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
  973. NCT00004810Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis
  974. NCT00004811Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis
  975. NCT00004812Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic…
  976. NCT00004814Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for…
  977. NCT00004815Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in…
  978. NCT00004816A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in…
  979. NCT00004817Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic…
  980. NCT00004825Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With…
  981. NCT00004826Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's…
  982. NCT00004827Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis…
  983. NCT00004828Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing…
  984. NCT00004829Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic…
  985. NCT00004831Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
  986. NCT00004832Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
  987. NCT00004833Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood…
  988. NCT00004834Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for…
  989. NCT00004838Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children
  990. NCT00004840Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent…
  991. NCT00004842Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
  992. NCT00004843A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary…
  993. NCT00004844Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's Disease
  994. NCT00004845A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
  995. NCT00004846Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV
  996. NCT00004847Diagnosis of Pheochromocytoma
  997. NCT00004848A Controlled Prospective Study of Transfusion-Associated Hepatitis
  998. NCT00004850Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
  999. NCT00004851Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune…
  1000. NCT00004852Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in…

About this dataset

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov